Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Jan;39(1):273–275. doi: 10.1128/aac.39.1.273

Effect of food on absorption of cefpodoxime proxetil oral suspension in adults.

M T Borin 1, K K Forbes 1
PMCID: PMC162526  PMID: 7695323

Abstract

The effect of a high-fat meal on absorption of a 200-mg dose of cefpodoxime proxetil oral suspension was evaluated in 20 healthy, male volunteers in a randomized, two-way crossover study. The concentrations of cefpodoxime in plasma and in urine were determined by sensitive and specific high-performance liquid chromatography methods. The area under the plasma drug concentration-time curve, time to peak concentration, and urinary excretion of cefpodoxime were significantly greater (P < or = 0.05) after administration of cefpodoxime proxetil oral suspension with food than under fasting conditions. However, the difference in the areas under the curve between fed and fasted treatments was only 11%, and application of the two one-sided tests procedure showed bioequivalence between treatments for this parameter. The slight increase in the extent of drug absorption and the slower rate of absorption which results when cefpodoxime proxetil is given with food are unlikely to be of clinical importance.

Full Text

The Full Text of this article is available as a PDF (181.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borin M. T., Hughes G. S., Patel R. K., Royer M. E., Cathcart K. S. Pharmacokinetic and tolerance studies of cefpodoxime after single- and multiple-dose oral administration of cefpodoxime proxetil. J Clin Pharmacol. 1991 Dec;31(12):1137–1145. doi: 10.1002/j.1552-4604.1991.tb03686.x. [DOI] [PubMed] [Google Scholar]
  2. Ducharme M. P., Edwards D. J., McNamara P. J., Stoeckel K. Bioavailability of syrup and tablet formulations of cefetamet pivoxil. Antimicrob Agents Chemother. 1993 Dec;37(12):2706–2709. doi: 10.1128/aac.37.12.2706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fujii R., Meguro H., Arimasu O., Shiraishi H., Abe T., Yoshioka H., Sakata H., Iseki K., Takahashi Y., Murono K. [Overall clinical evaluation of cefpodoxime proxetil against infections in pediatric fields]. Jpn J Antibiot. 1989 Jul;42(7):1439–1455. [PubMed] [Google Scholar]
  4. Hughes G. S., Heald D. L., Barker K. B., Patel R. K., Spillers C. R., Watts K. C., Batts D. H., Euler A. R. The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil. Clin Pharmacol Ther. 1989 Dec;46(6):674–685. doi: 10.1038/clpt.1989.204. [DOI] [PubMed] [Google Scholar]
  5. Iwai N., Taneda Y., Nakamura H., Miyazu M., Kasai K. [Pharmacokinetic, bacteriological and clinical evaluation of cefpodoxime proxetil in pediatrics]. Jpn J Antibiot. 1989 Jul;42(7):1571–1592. [PubMed] [Google Scholar]
  6. Koup J. R., Dubach U. C., Brandt R., Wyss R., Stoeckel K. Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans. Antimicrob Agents Chemother. 1988 Apr;32(4):573–579. doi: 10.1128/aac.32.4.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Schuirmann D. J. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm. 1987 Dec;15(6):657–680. doi: 10.1007/BF01068419. [DOI] [PubMed] [Google Scholar]
  8. Tam Y. K., Kneer J., Dubach U. C., Stoeckel K. Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteers. Antimicrob Agents Chemother. 1990 Aug;34(8):1556–1559. doi: 10.1128/aac.34.8.1556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Tremblay D., Dupront A., Ho C., Coussediere D., Lenfant B. Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses. J Antimicrob Chemother. 1990 Dec;26 (Suppl E):21–28. doi: 10.1093/jac/26.suppl_e.21. [DOI] [PubMed] [Google Scholar]
  10. Yokota T., Suzuki E., Arai K. Cefpodoxime proxetil, its in vitro antibacterial activity, affinity to bacterial penicillin-binding proteins, and synergy of bactericidal activity with serum complement and mouse-cultured macrophages. Drugs Exp Clin Res. 1988;14(8):495–500. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES